These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 22488081)
1. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Dunbar KB; Spechler SJ Am J Gastroenterol; 2012 Jun; 107(6):850-62; quiz 863. PubMed ID: 22488081 [TBL] [Abstract][Full Text] [Related]
2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
3. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? Konda VJ; Ferguson MK World J Gastroenterol; 2010 Aug; 16(30):3786-92. PubMed ID: 20698041 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related]
6. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review. Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766 [TBL] [Abstract][Full Text] [Related]
7. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Falk GW; Rice TW; Goldblum JR; Richter JE Gastrointest Endosc; 1999 Feb; 49(2):170-6. PubMed ID: 9925694 [TBL] [Abstract][Full Text] [Related]
8. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
9. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Rusch VW; Levine DS; Haggitt R; Reid BJ Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442 [TBL] [Abstract][Full Text] [Related]
10. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma. Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Scotiniotis IA; Kochman ML; Lewis JD; Furth EE; Rosato EF; Ginsberg GG Gastrointest Endosc; 2001 Dec; 54(6):689-96. PubMed ID: 11726843 [TBL] [Abstract][Full Text] [Related]
12. Esophagectomy for failed endoscopic therapy in patients with high-grade dysplasia or intramucosal carcinoma. Hunt BM; Louie BE; Dunst CM; Lipham JC; Farivar AS; Sharata A; Aye RW Dis Esophagus; 2014; 27(4):362-7. PubMed ID: 23795720 [TBL] [Abstract][Full Text] [Related]
13. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106 [TBL] [Abstract][Full Text] [Related]
14. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Yachimski P; Puricelli WP; Nishioka NS Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Zehetner J; DeMeester SR Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671 [TBL] [Abstract][Full Text] [Related]
16. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159 [TBL] [Abstract][Full Text] [Related]
17. Management controversies in Barrett's oesophagus. Max Almond L; Barr H J Gastroenterol; 2014 Feb; 49(2):195-205. PubMed ID: 23736794 [TBL] [Abstract][Full Text] [Related]